- Home
- OTLK vs FUSE Comparison
OTLK vs FUSE Comparison
Compare OTLK & FUSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OTLK | FUSE |
|---|---|---|
| Founded | 2010 | 2013 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.7M | 43.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OTLK | FUSE |
|---|---|---|
| Price | $0.40 | $1.46 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $3.83 | N/A |
| AVG Volume (30 Days) | 1.8M | ★ 11.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1,425.11 | N/A |
| Revenue Next Year | $129.89 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.38 | $1.45 |
| 52 Week High | $3.39 | $25.00 |
Technical Indicators
Market Signals| Indicator | OTLK | FUSE |
|---|---|---|
| Relative Strength Index (RSI) | 32.18 | 40.36 |
| Support Level | $0.38 | $1.55 |
| Resistance Level | $0.53 | $2.13 |
| Average True Range (ATR) | 0.05 | 0.36 |
| MACD | 0.04 | -0.05 |
| Stochastic Oscillator | 8.74 | 0.44 |
Price Performance
Historical ComparisonAbout OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About FUSE Fusemachines Inc.
Fusemachines Inc is a provider of enterprise AI products and solutions. The company provides good quality AI education in underserved communities and helping organizations achieve their full potential with AI. The products of the company include AI Studio, Answer Gen, GenAI Engines, and others.